In fiscal 2025, the PCC Group’s revenue amounted to € 923.6 million, representing a decrease of € 36.4 million, or 3.8 %, versus the previous year. This sales figure therefore fell below our revenue expectations for the 2025 fiscal year. The economic downturn in Europe, as well as uncertainty stemming from geopolitical developments, led to declines in prices and demand across a number of sectors. Combined with global trade conflicts and unclear US tariff policies, this resulted in further market distortions. In contrast, business areas with high resilience to such disruptions – such as the Surfactants & Derivatives segment, which includes products for the manufacture of cosmetics, personal care products, and industrial cleaners – actually increased their volumes in some cases, despite heightened competition. The trade conflicts between the USA and China, which have intensified since spring 2025, impacted global commodity flows. As a result of drastically increased US tariffs, ever-larger volumes of chemical precursors and silicon metal were diverted to Europe. The resulting further sharp decline in silicon metal prices in Europe subsequently made economic production at our plant in Iceland no longer viable. PCC BakkiSilicon hf. consequently suspended production temporarily in July 2025, causing revenue in the Silicon & Derivatives segment to roughly halve.
While the Surfactants & Derivatives and Logistics segments increased their revenue, the other segments recorded declines. In absolute terms, the Surfactants & Derivatives segment posted the largest sales increase at € 32.4 million and was thus also the Group’s main revenue driver. Capacity expansions supported this development. The Chlorine & Derivatives segment made the largest contribution to earnings before interest, taxes, depreciation, and amortization (EBITDA), followed by the Surfactants & Derivatives, Logistics, and Trading & Services segments. The only negative contribution came from the Silicon & Derivatives segment. Overall, the PCC Group closed the 2025 fiscal year with an EBITDA figure of € 81.4 million, € 6.6 million or 7.5 % less than in 2024. The increase in EBITDA included as part of the budgetary planning did not therefore materialize. Details of the varying business performance across the individual segments and the Group as a whole can be found in the following analysis. The PCC Group uses various performance indicators for financial performance management purposes. For the Group’s segments, sales revenue and EBITDA constitute the key financial performance indicators.
While the Surfactants & Derivatives and Logistics segments increased their revenue, the other segments recorded declines. In absolute terms, the Surfactants & Derivatives segment posted the largest sales increase at € 32.4 million and was thus also the Group’s main revenue driver. Capacity expansions supported this development. The Chlorine & Derivatives segment made the largest contribution to earnings before interest, taxes, depreciation, and amortization (EBITDA), followed by the Surfactants & Derivatives, Logistics, and Trading & Services segments. The only negative contribution came from the Silicon & Derivatives segment. Overall, the PCC Group closed the 2025 fiscal year with an EBITDA figure of € 81.4 million, € 6.6 million or 7.5 % less than in 2024. The increase in EBITDA included as part of the budgetary planning did not therefore materialize. Details of the varying business performance across the individual segments and the Group as a whole can be found in the following analysis. The PCC Group uses various performance indicators for financial performance management purposes. For the Group’s segments, sales revenue and EBITDA constitute the key financial performance indicators.
Sales by segment
G_L_03
